 remain relatively
intact.
6. CAS is preferred over CEA in symptomatic patients with
â±–50% stenosis and severe uncorrectable CAD, congestive heart failure, or chronic obstructive pulmonary disease (GRADE 2, Level of Evidence C). In making this a
GRADE 2 recommendation, the committee recognized
the difficulty in clearly defining this group of individuals,
both in symptomatology and risk assessment, and acknowledged the potential increased role of aggressive
medical management as